Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia

N Engl J Med. 2014 Dec 4;371(23):2239-41. doi: 10.1056/NEJMc1412035.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Arsenic / adverse effects
  • Arsenic / therapeutic use*
  • Female
  • Humans
  • Induction Chemotherapy
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Male
  • Middle Aged
  • Pilot Projects
  • Tretinoin / adverse effects
  • Tretinoin / therapeutic use*
  • Young Adult

Substances

  • Tretinoin
  • Arsenic